Modelling geographic variation in the cost-effectiveness of control policies for infectious vector diseases: The example of Chagas disease

Journal of Health Economics - Tập 27 - Trang 405-426 - 2008
Marianela Castillo-Riquelme1, Zaid Chalabi1, Joanne Lord2, Felipe Guhl3, Diarmid Campbell-Lendrum1, Clive Davies1, Julia Fox-Rushby4
1London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK
2National Institute for Health and Clinical Excellence, MidCity Place, 71 High Holborn, London WC1V 6NA, UK
3Centro de Investigaciones en Microbiología y Parasitoligia Tropical, Universidad de Los Andes, Bogotá, Colombia
4Brunel University, Uxbridge, Middlesex UB8 3PH, UK

Tài liệu tham khảo

Ades, 2004, Expected value of sample information calculations in medical decision modeling, Medical Decision Making, 24, 207, 10.1177/0272989X04263162 Akhavan, D., 1996. Análise de custo-efectividade do programa de controle da doença de Chagas no Brasil [Cost-effectiveness analysis of the Chagas disease control programme in Brasil]. Brasilia, Project BRA-093/15 with technical assistance from UN: 37. Basombrio, 1998, A cost-benefit analysis of Chagas disease control in north-western Argentina, Transactions of the Royal Society of Tropical Medicine & Hygiene, 92, 137, 10.1016/S0035-9203(98)90720-9 Bateman, 2003 Catala, 2004, Entomological aspects for Chagas’ disease transmission in the domestic habita, Argentina, Revista Panamericana de Salud Publica, 38, 216 Cecere, 2004, Spatio-temporal analysis of reinfestation by Triatoma infestans (Hemiptera: Redvuiidae) following insecticide spraying in a rural community in nortwestern Argentina, American Journal of Tropical Medicine and Hygiene, 71, 803, 10.4269/ajtmh.2004.71.803 Claborn, 2002, A cost comparison of two malaria control methods in Kyunggi Province, Republic of Korea, using remote sensing and geographic information systems, American Journal of Tropical Medicine and Hygiene, 66, 680, 10.4269/ajtmh.2002.66.680 Claxton, 1999, Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals, Health Economics, 8, 269, 10.1002/(SICI)1099-1050(199905)8:3<269::AID-HEC425>3.0.CO;2-D Claxton, 2001, Bayesian value-of-information analysis An application to a policy model of Alzheimer's disease, International Journal of Technology Assessment in Health Care, 17, 38, 10.1017/S0266462301104058 Coyle, 2003, Measures of importance for economic analysis based on decision modeling, Journal of Clinical Epidemiology, 56, 989, 10.1016/S0895-4356(03)00176-8 De Andrade, 1995, Risk factors for Trypansoma cruzi infection among children in central Brazil: a case–control study in vector control settings, American Journal of Tropical Medicine and Hygiene, 52, 183, 10.4269/ajtmh.1995.52.183 Diotaiuti, 2000, Operational aspects of Triatoma brasiliensis control, Cadernos de Saude Publica, 16, 61, 10.1590/S0102-311X2000000800006 Drummond, 2001, Transferability of economic evaluation results Dumonteil, 2004, Predicting Triatoma dimidiata abundance and infection rate: a risk map for natural transmission of Chagas disease in Yucatan Peninsula of Mexico, American Journal of Tropical Medicine and Hygiene, 70, 514, 10.4269/ajtmh.2004.70.514 Dumonteil, 2004, Re-infestation of houses by Triatoma dimidiata after intra-domicile insecticide application in the Yucatan peninsula, Mexico, Memorias do Instituto Oswaldo Cruz, 99, 253, 10.1590/S0074-02762004000300002 Fox-Rushby, 2002 Guhl, 2005, Lessons from a national survey of Chagas disease transmission risk in Colombia, Trends in Parasitology, 21, 259, 10.1016/j.pt.2005.04.011 Gurtler, 2005, Incidence of Trypanosoma cruzi infection among children following domestic reinfestation after insecticide spraying in rural northwestern Argentina, American Journal of Tropical Medicine and Hygiene, 73, 95, 10.4269/ajtmh.2005.73.95 Gurtler, 2004, Effectiveness of residual spraying of peridomestic ecotopes with deltamethrin and permethrin on Triatoma infestans in rural western Argentina: a district-wide randomized trial, Bulletin of the World Health Organization, 82, 196 Gurtler, 1999, Monitoring house reinfestation by vectors of Chagas disease: a comparative trial of detection methods during a four-year follow-up, Acta Tropica, 72, 213, 10.1016/S0001-706X(98)00096-5 Gurtler, 1998, Household prevalence of seropositivity for Trypanosoma cruzi in three rural villages in northwest Argentina: environmental, demographic, and entomologic associations, American Journal of Tropical Medicine and Hygiene, 59, 741, 10.4269/ajtmh.1998.59.741 Hutubessy, 2003, Generalized cost-effectiveness analysis for national-level priority-setting in the health sector, Cost-effectiveness and Resource Allocation, 1, 1 Laska, 1999, Ratio-based and net benefit-based approaches to health care resource allocation: proofs of optimality and equivalence, Health Economics, 8, 171, 10.1002/(SICI)1099-1050(199903)8:2<171::AID-HEC424>3.0.CO;2-E Lord, 2005, Non-linearity in the cost-effectiveness frontier, Health Economics, 15, 565, 10.1002/hec.1083 Ministerio de la Protecion Social, INS and OPS, 2003. Situación de Salud en Colombia, Indicadores básicos 2003, Ministerio de la Proteccion Social, 16 pp. Mott, 1978, House construction, traitomine distribution, and household distribution of seroreactivity to Trypanosoma cruzi in a rural communicty in northeast Brasil, American Journal of Tropical Medicine and Hygiene, 27, 1116, 10.4269/ajtmh.1978.27.1116 Mulligan, J., Fox-Rushby, J., Adam, T., et al., 2003. Unit costs of health care inputs in low and middle income regions. Disease Control Priorities Project. http://www.fic.nih.gov/dcpp/wps/wp9.pdf. Mullner, 2004, Geographic information systems in public health and medicine, Journal of Medical Systems, 28, 215, 10.1023/B:JOMS.0000032972.29060.dd Murray, C.J.L., 1996. The global burden of disease, a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Oliveira Filho, 2000, Focal and total residual insecticide spraying to control Triatoma brasiliensis and Triatoma pseudomaculata in Northeast Brazil, Cadernos de Saude Publica, 16, 105, 10.1590/S0102-311X2000000800014 Piesman, 1985, Association between household triatomine density and incidence of Trypansoma cruzi infection during a nine-year study in Castro Alves, Bahia Brazil, American Journal of Tropical Medicine and Hygiene, 34, 866, 10.4269/ajtmh.1985.34.866 Rabinovich, 1995, Density estimates of the domestic vector of Chagas disease, Rhodnius prolixus Stal (Hemipetra: Reduviidae), in rural houses in Venezuela, Bulletin of the World Health Organization, 73, 347 Ramsey, 2003, Efficacy of pyrethroid insecticides against domestic and peridomestic populations of Triatoma pallidipennis and Traitoma berberi (Reduviida: Triatominae) vectors of Chagas disease in Mexico, Journal of Medical Entomology, 40, 912, 10.1603/0022-2585-40.6.912 Romana, 1999, Palm trees as ecological indicators of risk areas for Chagas disease, Transactions of the Royal Society of Tropical Medicine and Hygiene, 93, 594, 10.1016/S0035-9203(99)90059-7 Schenone, 1998, Human infection by Trypanosoma cruzi in Chile: epidemiology estimates and costs of care and treatment of the Chagasic patient] [Spanish], Boletin Chileno de Parasitologia, 53, 23 Schofield, 1991, A cost-benefit analysis of Chagas disease control, Memorias do Instituto Oswaldo Cruz, 86, 285, 10.1590/S0074-02761991000300002 Schofield, C.J., 2000. Challenges of Chagas disease vector control in Central America. WHO/CDS/WHOPES/GCDPP/2000.1. Sculpher, 2004, Generalisability in economic evaluation studies in healthcare: a review and case studies, Health Technology Assessment, 8, 10.3310/hta8490 Sosa-Jurado, 2004, Biotic and abiotic determinants of seroprevalence of antibodies against Trypanosoma cruzi in Palmar de Bravo, Puebla Mexico, Salud Publica de Mexico, 46, 39, 10.1590/S0036-36342004000100006 Tan-Torres Edejer, 2003 Walker, 2000, The internal and external validity of economic evaluations in parasitic disease, Tropical Medicine and International Health, 5, 237, 10.1046/j.1365-3156.2000.00546.x WHO, 2002. Control of Chagas disease. WHO Technical Report Series 905, Geneva, WHO. Willke, 1998, Estimating country-specific cost-effectiveness from multinational clinical trials, Health Economics, 7, 481, 10.1002/(SICI)1099-1050(199809)7:6<481::AID-HEC353>3.0.CO;2-K